Mirum Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $842.8M
Liabilities Breakdown FY2025
Total Liabilities: $528.1M
Asset Breakdown
Total Assets: $842.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $296.7M | 35.2% |
| Accounts Receivable | $123.3M | 14.6% |
| Inventory | $24.9M | 3.0% |
| Property, Plant & Equipment | $1.9M | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $260.9M | 31.0% |
| Other Assets | $135.1M | 16.0% |
Liabilities Breakdown
Total Liabilities: $528.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.6M | 1.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $518.5M | 98.2% |